AGTHX
Price
$76.88
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
FOCPX
Price
$20.29
Change
-$0.06 (-0.29%)
Updated
Sep 20 closing price
Ad is loading...

AGTHX vs FOCPX

Header iconAGTHX vs FOCPX Comparison
Open Charts AGTHX vs FOCPXBanner chart's image
American Funds Growth Fund of Amer A
Price$76.88
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
Fidelity OTC
Price$20.29
Change-$0.06 (-0.29%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AGTHX vs FOCPX Comparison Chart
Loading...
VS
AGTHX vs. FOCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTHX is a StrongBuy and FOCPX is a Buy.

FUNDAMENTALS
Fundamentals
AGTHX has more cash in the bank: 290B vs. FOCPX (30.7B). AGTHX pays higher dividends than FOCPX: AGTHX (0.49) vs FOCPX (0.05). AGTHX was incepted earlier than FOCPX: AGTHX (51 years) vs FOCPX (40 years). AGTHX is a more actively managed with annual turnover of: 31.00 vs. FOCPX (15.00). FOCPX has a lower initial minimum investment than AGTHX: FOCPX (0) vs AGTHX (250). AGTHX annual gain was more profitable for investors over the last year : 23.76 vs. FOCPX (19.29). FOCPX return over 5 years is better than : 71.89 vs. AGTHX (50.99).
AGTHXFOCPXAGTHX / FOCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence51 years40 years-
Gain YTD19.3168.529226%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets290B30.7B945%
Annual Yield % from dividends0.490.051,016%
Returns for 1 year23.7619.29123%
Returns for 3 years-3.111.08-289%
Returns for 5 years50.9971.8971%
Returns for 10 years63.05148.2843%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSSS3.870.02
+0.52%
SuRo Capital Corp
KRT25.94-0.01
-0.04%
Karat Packaging
PR13.86-0.02
-0.14%
Permian Resources Corp
TNDM42.64-0.42
-0.98%
Tandem Diabetes Care
RSLS0.16-0.01
-3.16%
ReShape Lifesciences